The FOXD3 immunoreactivity was significantly higher in NB cases with good differentiation (P < 0.001), lower mitosis karyorrhexis index (MKI) (P = 0.003), and early INSS stages (P = 0.018) (Table S1). This evidence concerns the gene FOXD3 and neuroblastoma.